Financial publications

Update Q3 2022
(2 MB)
Half-Year Financial Report 2022
(4 MB)
Update Q1 2022
(2 MB)
Investor Presentation Q3 2022
(2 MB)
Investor Presentation H1 2022
(2 MB)
Investor Presentation Q1 2022
(1 MB)
Investor Presentation LSX Inv€$tival November 2022
(2 MB)
Investor Presentation Equity Forum 2022
(2 MB)
Conference Call Invitation Results Q3 2022
(47 KB)
Conference Call Invitation - Half Year Results 2022
(70 KB)
Conference Call Invitation - Results Q1 2022
(67 KB)
Annual Report 2021
(2 MB)
Sustainability Report 2021 (excerpt from Annual Report 2021)
(944 KB)
Financial Report 2021
(2 MB)
Jahresfinanzbericht 2021 (ESEF)
(1 MB)
Update Q3 2021
(176 KB)
Half-Year Financial Report 2021
(385 KB)
Update Q1 2021
(168 KB)
Investor Presentation - Full Year Results 2021
(4 MB)
Investor Presentation Q3 2021
(2 MB)
Investor Presentation H1 2021
(960 KB)
Investor Presentation Q1 2021
(1 MB)
Conference Call Invitation - Full Year Results 2021
(140 KB)
Conference Call Invitation - Results Q3 2021
(138 KB)
Conference Call Invitation - Half-Year Results 2021
(127 KB)
Conference Call Invitation - Results Q1 2021
(47 KB)
Bericht des Vorstands der Marinomed Biotech AG FN 276819 m, ISIN ATMARINOMED6 gemäß § 174 Abs 4 iVm § 153 Abs 4, § 171 Abs 1 AktG (German Only)
(106 KB)
Annual Report 2020
(938 KB)
Jahresfinanzbericht 2020 (ESEF)
(248 KB)
Financial Report 2020
(837 KB)
Update Q3 2020
(178 KB)
Half-Year Financial Report 2020
(329 KB)
Update Q1 2020
(141 KB)
Investor Presentation - Results FY 2020
(1 MB)
Investor Presentation Q3 2020
(584 KB)
Investor Presentation SARS-CoV-2
(345 KB)
Investor Presentation H1 2020
(918 KB)
Investor Presentation Q1 2020
(574 KB)
Conference Call Invitation - Full Year Results 2020
(132 KB)
Conference Call Invitation - Results Q3 2020
(61 KB)
Conference Call Invitation - Results H1 2020
(61 KB)
Conference Call Invitation - Results Q1 2020
(59 KB)
Veröffentlichung gemäß § 5 Abs. 2 Rechnungslegungs-Kontrollgesetz (RL-KG) vom 04.09.2020 (German only)
(25 KB)
Annual Report 2019
(1 MB)
Financial Report 2019
(2 MB)
Update Q3 2019
(678 KB)
Half-Year Financial Report 2019 incl. UGB
(1 MB)
Half-Year Financial Report 2019
(845 KB)
Update Q1 2019
(690 KB)
Investor Presentation - Results FY 2019
(965 KB)
Investor Presentation Q3 2019
(676 KB)
Investor Presentation H1 2019
(999 KB)
Financial Report 2018
(2 MB)
Annual Report 2018
(3 MB)
Investors Update 2018
(832 KB)
Annual Report 2017
(2 MB)
Audit report (German only)
(2 MB)
Stephanie Kniep, Dipl.-Ök.
Head of Investor Relations
Marinomed Biotech AG
Hovengasse 25
2100 Korneuburg, Austria
+43 2262 90300
office@marinomed.com